Chordoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Chordoma}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Oncology {{WikiDoc Help Menu}} {{WikiDoc Sour...") |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
There are no drugs currently approved to treat chordoma, however chordoma has been shown to have a limited response to the [[PDGFR]] inhibitor [[Imatinib]].<ref name="pmid15372471">{{cite journal |author=Casali PG, Messina A, Stacchiotti S, ''et al'' |title=Imatinib mesylate in chordoma |journal=Cancer |volume=101 |issue=9 |pages=2086-97 |year=2004 |pmid=15372471 |doi=10.1002/cncr.20618}}</ref> | |||
==References== | ==References== | ||
Revision as of 18:18, 19 January 2012
|
Chordoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chordoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Chordoma medical therapy |
|
Risk calculators and risk factors for Chordoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There are no drugs currently approved to treat chordoma, however chordoma has been shown to have a limited response to the PDGFR inhibitor Imatinib.[1]
References
- ↑ Casali PG, Messina A, Stacchiotti S; et al. (2004). "Imatinib mesylate in chordoma". Cancer. 101 (9): 2086–97. doi:10.1002/cncr.20618. PMID 15372471.